MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of a language-agnostic artificial intelligence speech model capable of detecting drug and alcohol intoxication across multiple languages. The innovation advances scalable, non-invasive testing for industries requiring high-volume safety screening, such as mining, aviation, construction, and law enforcement.

The AI prediction model leverages over 50 million data points to predict alcohol intoxication with high accuracy using only the human voice. The company is building an enterprise platform, including Edge-AI kiosks that integrate bespoke hardware and software for intoxication detection in real-world environments. This approach eliminates the need for traditional biological samples, enabling rapid, contactless screening.

The announcement, disseminated via AINewsBreaks, underscores the potential of AI to transform workplace safety protocols. By operating across languages, the model addresses a critical limitation of existing voice-based systems, which often require language-specific training data. This cross-language capability could facilitate global deployment in multilingual workforces.

MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for intoxication detection. The company's focus on voice analysis positions it within a growing market for non-invasive screening tools. The development follows increasing regulatory and corporate emphasis on safety in high-risk industries.

For more information about MindBio Therapeutics, visit the company's newsroom at https://ibn.fm/MBQIF.